Nurix Therapeutics Stock Forecast

Stock Price Forecast

The 16 analysts with 12-month price forecasts for Nurix Therapeutics stock have an average target of 31.75, with a low estimate of 17 and a high estimate of 41. The average target predicts an increase of 88.20% from the current stock price of 16.87.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$17	$31.75	$35	$41
Change	+0.77%	+88.20%	+107.47%	+143.03%

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	4	6	6	7	7	7
Buy	8	8	8	9	9	8
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	15	15	17	17	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Maintains $16 → $17	Hold	Maintains	$16 → $17	+0.77%	Feb 3, 2025
Gregory Renza RBC Capital	RBC Capital	Buy Maintains $26 → $27	Buy	Maintains	$26 → $27	+60.05%	Jan 29, 2025
Eric Joseph JP Morgan	JP Morgan	Buy Maintains $31 → $30	Buy	Maintains	$31 → $30	+77.83%	Jan 29, 2025
Stephen Willey Stifel	Stifel	Strong Buy Maintains $34 → $36	Strong Buy	Maintains	$34 → $36	+113.40%	Jan 29, 2025
Gil Blum Needham	Needham	Strong Buy Maintains $29 → $28	Strong Buy	Maintains	$29 → $28	+65.98%	Jan 29, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

56.34M

from 54.55M

3.28%

from 54.55M

Revenue Next Year

60.13M

from 56.34M

6.73%

from 56.34M

EPS This Year

-3.17

from -2.88

EPS Next Year

-3.29

from -3.17

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Nov 30, 2020	Nov 30, 2021	Nov 30, 2022	Nov 30, 2023	Nov 30, 2024	Nov 30, 2025	Nov 30, 2026	Nov 30, 2027
Revenue	17.82M	29.75M	38.63M	76.99M	54.55M	56.34M	60.13M	88.87M
Revenue Growth	-42.73%	66.95%	29.84%	99.31%	-29.15%	3.28%	6.73%	47.79%
EPS	-2.76	-2.73	-3.71	-2.65	-2.88	-3.17	-3.29	-3.34
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	19	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	84.0M	89.3M	212.1M
Avg	56.3M	60.1M	88.9M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	54.0%	58.4%	252.7%
Avg	3.3%	6.7%	47.8%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-2.08	-1.70	-1.89
Avg	-3.17	-3.29	-3.34
Low	-3.74	-4.68	-4.20

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.